ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VRTX announcements Vertex Pharmaceuticals Incorporated announcements and dividends declared NASDAQ

Vertex Pharmaceuticals Incorporated Complete list of announcements declared & dividend announcements by Vertex Pharmaceuticals Incorporated VRTX

Vertex Pharmaceuticals Incorporated VRTX listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Vertex Pharmaceuticals Incorporated VRTX

Vertex Pharmaceuticals (BER:VX1) Price Target Increased by 10.91% to 341.78
The average one-year price target for Vertex Pharmaceuticals (BER:VX1) has been revised to 341.78 / share. This is an increase of 10.91% from the prior estimate of 308.16 dated April 6, 2023. The price target is an average of many targets provided by anal
Announcement as on 21 May 2023

Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Announcement as on 02 May 2023

Why Shares of Vertex Pharmaceuticals Jumped 9.03% on Friday
What happened Shares of Vertex Pharmaceuticals (NASDAQ: VRTX), a biopharmaceutical stock that specializes in cystic fibrosis (CF) and gene-editing therapies, saw its shares jump 9.03% on Friday. The stock closed at 7.89 on Thursday, then opened on Frida
Announcement as on 28 October 2022

Vertex Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) have crossed above the average analyst 12-month target price of 3.89, changing hands for 0.50/share. When a stock reaches the target an analyst has set, the analyst logically h
Announcement as on 25 October 2022

What's Driving Vertex Pharmaceuticals Stock Higher?
Vertex Pharmaceuticals stock (NASDAQ: VRTX) has seen a 33% rise this year, significantly outperforming the broader S&P500 index, down 23%. Even if we look at the longer term, VRTX stock, with 72% returns from levels seen in late 2018, has outperformed the
Announcement as on 30 September 2022

Announcements by Vertex Pharmaceuticals Incorporated first page | Next page | Prev page |

VRTX Vertex Pharmaceuticals Incorporated current price & indicator signals

Moving Averages for Vertex Pharmaceuticals Incorporated

  • 5Day Average: 446.94
  • 12Day Average: 435.37
  • 20Day Average: 433
  • 50Day Average: 421.19
  • 100Day Average: 414.25
  • 150Day Average: 426.21
  • 200Day Average: 442.36

VRTX Indicators & signals

Indicator MACD (12,26,9)

440.45, 432.12, 5.7
Indicator MACD is in positive zone

Indicator ADX (14)

43.41, 26.72, 10.55
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VRTX Vertex Pharmaceuticals Incorporated are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 455.48 454.45 to 462.00 -0.41% 0.59 times
04 Thu Dec 2025 457.36 453.54 to 463.70 -1.25% 0.99 times
03 Wed Dec 2025 463.13 439.35 to 463.85 6.92% 1.65 times
02 Tue Dec 2025 433.15 424.06 to 435.20 1.77% 0.91 times
01 Mon Dec 2025 425.60 423.45 to 434.00 -1.85% 0.76 times
28 Fri Nov 2025 433.61 429.07 to 434.67 0.33% 0.47 times
26 Wed Nov 2025 432.17 428.07 to 433.32 0.55% 0.75 times
25 Tue Nov 2025 429.82 424.12 to 431.50 1.37% 1.01 times
24 Mon Nov 2025 424.00 423.87 to 432.55 -0.65% 1.44 times
21 Fri Nov 2025 426.76 421.87 to 435.85 1.05% 1.25 times
20 Thu Nov 2025 422.32 420.00 to 431.13 0.31% 0.77 times
19 Wed Nov 2025 421.03 418.53 to 434.93 -3.33% 1 times

Videos related to: VRTX announcements Vertex Pharmaceuticals Incorporated announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

VRTX announcements Vertex Pharmaceuticals Incorporated announcements and dividends declared NASDAQ

 

Back to top